Our latest exploration of recently published HIV-related research turned up these clinically noteworthy new findings:
- Emergency care clinicians in the U.S. may be inadvertently passing up key opportunities to prescribe PrEP to at-risk people.
- Effective antiretroviral therapy appears to bring an additional long-term benefit: lower risk of cancer.
- Many sexual health clinics could be doing more to identify people with HIV who are out of care and reconnect them.
- A proof-of-concept trial suggests neurocognitive benefits of low-dose hydrocortisone therapy for women living with HIV.
Come along with us as we take a closer look at each of these intriguing studies. To beat HIV, you have to follow the science!